Organism company, Ginkgo Bioworks and Twist Bioscience Corporation have announced the expansion of a supply agreement for one billion base pairs of synthetic DNA, accounting for the largest volume supply agreement in the industry. The supply agreement will include genes up to five kilobases in length.

Ginkgo intends to use the one billion base pairs of synthetic DNA for work in its newest automated foundry for organism design, Bioworks3, opening in November 2017. The third foundry will be used in part by the new company that Ginkgo and Bayer recently launched with $100M in Series A funding focused on nitrogen fixation for sustainable agriculture. This supply of synthetic DNA will also fuel Ginkgo’s continued expansion into new industries for a wider breadth of companies to leverage the power of biology in their lines of business.

“An increasingly diverse scope of companies are looking to tap the power of biology to rethink traditional manufacturing, and demand for synthetic biology is at an all-time high,” said Jason Kelly, CEO and co-founder of Ginkgo Bioworks. “Our continued partnership with Twist allows us to meet those demands and scale our work so we can continue to bring biology to new industries. We’re excited to be at the forefront of this shift and Twist is a critical part of the equation.”

Twist Bioscience has been supplying synthetic DNA to Ginkgo Bioworks since November of 2015, when the companies announced an agreement for Twist Bioscience to deliver a minimum of 100 million base pairs of synthetic DNA over the course of 2016, a quantity equal to approximately 10% of the total DNA synthesis market in 2015. Ginkgo is the largest consumer of synthetic DNA globally, and with this supply expansion, it is expected to order approximately one third of the global supply of synthetic DNA.

Emily M. Leproust, Ph.D., CEO of Twist Bioscience, commented, “We are thrilled to enable Ginkgo’s exponential expansion as we are the only provider of synthetic DNA capable of supporting their rapidly increasing DNA needs. Our ongoing collaboration, pairing Ginkgo’s tremendous organism design capabilities and Twist Bioscience’s core DNA synthesis scalability, showcases the growth of the bioeconomy by enabling the development of sustainable methods for producing new and important consumer goods.”